FDA Science & Technology Vendor Show

CBER/FDA wants the latest Biologics relevent laboratory equipment, reagents, services and supplies.

The Food and Drug Administrations Center for Biologics Evaluation and Research (FDA/CBER) will host an FDA Science & Technology Vendor Show at FDA Headquarters in Silver Spring, MD to ensure that FDA researchers and regulatory scientists are aware of the latest and most cutting-edge equipment and products that will allow CBER to continue to carry out cutting edge science to meet the regulatory mission of FDA.

CBER scientists will take the information it obtains from the vendor show into account as it determines what type of equipment, reagents, services, and supplies that should be a part of the CBER laboratory infrastructure in the future.

BACKGROUND

CBER/FDA wants to maintain cutting edge research and regulatory laboratories with the latest equipment, reagents, services and supplies relevant to Biologics. For the FDA Science & Technology Vendor Show, CBER is specifically interested in the latest and most cutting-edge equipment and products in the following areas:

• Flow Cytometers
• Next-Generation Flow Cytometry
• Single Cell Sequencing & New Rapid Sequencing Technologies
• Spectrophotometers
• Mass spectrophotometers
• New Generation of DNA/RNA Sequencing Technologies
• Microplate Readers
• Pipettors (self-calibrating)
• Protein Purification, Protein Expression
• Quantitative Proteomics (particularly multiple reaction monitoring multiplexing)
• Molecular Diagnostics Analyzers
• Hybrid Protein/RNA Detection Technology
• Sterility Testing Systems
• Microscopy
• Bioreactors (high throughput, customizable)
• Advanced Analytical Technologies
• Hybrid protein/RNA detection Technology
• Contract Services for MHC-associated peptide proteomics (MAPPS) assay service, high throughput sequencing and data analysis

EVENT

FDA Science & Technology Vendor Show

DATE AND TIME

November 6, 2023, 11:00 AM – 2:00 PM Eastern Time (ET).

Check-in and set up begins at 9:00 AM ET.

LOCATION

FDA White Oak Campus Atrium
10903 New Hampshire Avenue, Building 75 Atrium
Silver Spring, Maryland 20993

SUBMISSION INSTRUCTIONS

In response to this SPECIAL NOTICE, Vendors interested in attending the Science Vendor Fair shall send an email to CBERADRTEAM@FDA.HHS.GOV with subject line 2023 FDA Science & Technology Vendor Show. A capability form will be emailed to you. The capability form should be returned by October 20, 2023.

Vendors selected to exhibit at the 2023 FDA Science & Technology Vendor Show will be notified no later than October 27, 2023.

Given limited space, Vendors are allowed no more than two (2) representatives TOTAL and FDA reserves the right to reduce that number to one (1) to mitigate overcrowding if necessary. Individual divisions or groups of a single company are considered a single parent company (please coordinate internally to submit ONE response).

LATE SUBMISSIONS

Responses to the SPECIAL NOTICE received by FDA after the submittal deadline and time indicated may be considered if space is available.

QUESTIONS

Should you have any questions email CBERADSTEAM@FDA.HHS.GOV.

SPECIAL ACCOMODATIONS

The FDA is committed to providing access to all individuals attending this FDA Science & Technology Vendor Fair. If you require special accommodations (e.g., sign language, etc.), please provide this information to CBERADSTEAM@FDA.HHS.GOV before October 27, 2023.

VISITOR PARKING

Attendees must park in FDA’s visitor parking lots. See link below for driving directions and parking at the FDA White Oak Campus. https://www.fda.gov/about-fda/visitor-information/visitor-parking-and-campus-map

DISCLAIMERS

This SPECIAL NOTICE is issued solely to survey the market and does not constitute a solicitation. Neither unsolicited proposals nor any other kind of offers will be considered in response to this NOTICE. Responses to this notice are not offers and will not be accepted by the Government to form a binding contract. Respondents are solely responsible for all expenses associated with responding to this NOTICE. All information received in response to this NOTICE marked as "proprietary" will be handled accordingly. Information provided as a response to the NOTICE will not be returned. FDA/CBER will not entertain any questions concerning the composition, requirements, or the nature of services to be performed under any future request for proposal (RFP).

All informational material submitted in response to this request becomes property of FDA.

Under no circumstances shall FDA be responsible for any response preparation expenses, submission costs, or any other expenses, costs, or damages, of whatever nature incurred as a result of the Respondents participation in this market research process. Respondent understands and agrees that it submits its response at its own risk and expense, and releases FDA from any claim for damages or other liability arising out of this SPECIAL NOTICE.

FDA shall not be liable for any errors in the Respondents response. Respondent is responsible for careful review of its entire response to ensure that all information is correct and complete. Respondents are liable for all errors or omissions contained in their responses.

FDA reserves the right to issue an addendum to this SPECIAL NOTICE at any time for any reason.

Attachments/Links